RG
ZYME icon

Redmile Group’s Zymeworks ZYME Stock Holding History

Redmile Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Hold
491,654
– – 0.86% 24
2026
Q1 		$12.3M Hold
491,654
– – 0.82% 20
2025
Q4 		$12.9M Sell
491,654
-3,214,096
-87% -$70.1M 0.95% 18
2025
Q3 		$63.3M Sell
3,705,750
-444,877
-11% -$6.37M 6.16% 4
2025
Q2 		$52.1M Sell
4,150,627
-638,318
-13% -$7.6M 5.54% 3
2025
Q1 		$57M Sell
4,788,945
-51,518
-1% -$703K 5.39% 4
2024
Q4 		$70.9M Sell
4,840,463
-261,448
-5% -$3.66M 4.94% 4
2024
Q3 		$64M Sell
5,101,911
-109,126
-2% -$1.19M 3.77% 6
2024
Q2 		$44.3M Sell
5,211,037
-349,761
-6% -$3.11M 2.68% 12
2024
Q1 		$58.5M Sell
5,560,798
-229,432
-4% -$2.55M 2.15% 15
2023
Q4 		$60.2M Buy
5,790,230
+129,000
+2% +$1.03M 2.15% 11
2023
Q3 		$35.9M Hold
5,661,230
– – 1.71% 18
2023
Q2 		$48.9M Sell
5,661,230
-406,688
-7% -$3.64M 1.88% 12
2023
Q1 		$54.9M Sell
6,067,918
-108,000
-2% -$942K 2.38% 11
2022
Q4 		$48.5M Buy
6,175,918
+410,100
+7% +$2.88M 1.99% 18
2022
Q3 		$35.5M Buy
5,765,818
+1,930,000
+50% +$11.6M 1.38% 23
2022
Q2 		$20.3M Buy
3,835,818
+1,721,621
+81% +$10.4M 0.78% 35
2022
Q1 		$13.8M Buy
2,114,197
+1,239,800
+142% +$11M 0.43% 49
2021
Q4 		$14.3M Sell
874,397
-7,700
-0.9% -$161K 0.33% 54
2021
Q3 		$25.6M Sell
882,097
-57,600
-6% -$1.91M 0.45% 48
2021
Q2 		$32.6M Sell
939,697
-46,003
-5% -$1.46M 0.48% 52
2021
Q1 		$31.1M Sell
985,700
-102,600
-9% -$4.17M 0.44% 58
2020
Q4 		$51.4M Sell
1,088,300
-13,300
-1% -$618K 0.62% 46
2020
Q3 		$51.3M Buy
1,101,600
+318,100
+41% +$10.9M 0.94% 37
2020
Q2 		$28.3M Sell
783,500
-85,100
-10% -$3.13M 0.52% 50
2020
Q1 		$30.8M Buy
+868,600
New +$35.5M 0.86% 38

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Redmile Group's ZYME Position: Q2 2026 in Review

Redmile Group held its Zymeworks (ZYME) position steady in Q2 2026 at 491,654 shares worth $12.9M. The position accounts for 0.86% of the portfolio, ranked #24.

Redmile Group first reported a position in ZYME in Q1 2020 and has held it in 26 quarters since. The position peaked at $70.9M in Q4 2024. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Redmile Group held 491,654 shares of Zymeworks worth $12.9M as of Q2 2026.
  • Redmile Group left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up 0.86% of Redmile Group's portfolio in Q2 2026, its #24 holding.
  • Redmile Group first reported a position in Zymeworks in Q1 2020 and has held it in 26 quarters since.
  • Redmile Group's Zymeworks position peaked at $70.9M in Q4 2024.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Redmile Group's 13F filing for Q2 2026, filed 14 Aug 2026.